@sandoz.com
Sandoz is a global leader in off-patent medicines, based on our strong scientific heritage.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Logo
SVG
Icon
JPEG
About
Description
Sandoz, a subsidiary of the renowned pharmaceutical company Novartis, is a leading global provider of generic and biosimilar medicines. Established in Germany in 1886, Sandoz has grown to become a key player in the global pharmaceutical market. Sandoz's headquarters are located in Holzkirchen, Germany.
This strategically situated location enables the company to access advanced scientific and technological resources in Germany, while also fostering strong connections with Novartis' global network. The company offers a wide range of high-quality generic pharmaceutical products, including prescription medicines, over-the-counter drugs, and biopharmaceuticals. Sandoz also specializes in the development and production of biosimilars, which are biologic drugs that are highly similar to their reference products.
These products provide greater access to effective treatments and contribute to cost savings in the healthcare sector. Sandoz operates on a global scale, with a presence in more than 160 countries. The company has a number of noteworthy subsidiaries, joint ventures, and partnerships.
For instance, Sandoz has collaborations with leading healthcare organizations such as Amgen and Pfizer to develop and commercialize innovative biosimilars. With its extensive product portfolio and global market reach, Sandoz holds a strong market position. The company consistently ranks among the top players in the global generic pharmaceutical industry.
In terms of global sales, Sandoz generates substantial revenue, contributing to Novartis' overall success in the healthcare sector. Throughout its history, Sandoz has achieved several significant milestones. One noteworthy event was the successful launch of the world's first biosimilar medicine, Omnitrope, in Europe in 2006.
This marked a major advancement in improving patient access to high-quality, affordable biologic therapies. Currently, Sandoz continues to innovate and expand its product offerings. The company regularly launches new generic drugs and biosimilars, addressing the evolving needs of patients and healthcare systems worldwide.
Sandoz remains committed to providing cost-effective, high-quality medicines and driving improvements in global healthcare. In conclusion, Sandoz is a leading global provider of generic and biosimilar medicines. With a strong market position, extensive product portfolio, and global operations, the company continues to make significant contributions to the pharmaceutical industry.
By offering affordable and accessible healthcare solutions, Sandoz plays a vital role in improving patient outcomes and advancing global healthcare
Company Type
Public Company
Company Size
10,001+
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories